DIAMOX Drug Patent Profile
✉ Email this page to a colleague
When do Diamox patents expire, and when can generic versions of Diamox launch?
Diamox is a drug marketed by Teva Branded Pharm and Teva Womens and is included in three NDAs.
The generic ingredient in DIAMOX is acetazolamide sodium. There are ten drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diamox
A generic version of DIAMOX was approved as acetazolamide sodium by HIKMA on February 28th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIAMOX?
- What are the global sales for DIAMOX?
- What is Average Wholesale Price for DIAMOX?
Summary for DIAMOX
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 125 |
| Clinical Trials: | 56 |
| Patent Applications: | 3,763 |
| Drug Prices: | Drug price information for DIAMOX |
| DailyMed Link: | DIAMOX at DailyMed |
Recent Clinical Trials for DIAMOX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 2 |
| University of Puget Sound | Phase 4 |
US Patents and Regulatory Information for DIAMOX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | DIAMOX | acetazolamide | CAPSULE, EXTENDED RELEASE;ORAL | 012945-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Branded Pharm | DIAMOX | acetazolamide | TABLET;ORAL | 008943-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Womens | DIAMOX | acetazolamide sodium | INJECTABLE;INJECTION | 009388-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Branded Pharm | DIAMOX | acetazolamide | TABLET;ORAL | 008943-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
